Scaldaferri, Franco
 Distribuzione geografica
Continente #
EU - Europa 6.367
NA - Nord America 6.091
AS - Asia 2.988
SA - Sud America 376
AF - Africa 74
OC - Oceania 38
Continente sconosciuto - Info sul continente non disponibili 17
Totale 15.951
Nazione #
US - Stati Uniti d'America 6.002
DE - Germania 1.518
SE - Svezia 1.282
IT - Italia 1.255
SG - Singapore 1.037
CN - Cina 997
FR - Francia 446
IE - Irlanda 349
UA - Ucraina 332
BR - Brasile 318
PL - Polonia 266
ID - Indonesia 236
GB - Regno Unito 219
FI - Finlandia 184
IN - India 172
RU - Federazione Russa 135
TR - Turchia 116
IR - Iran 107
NL - Olanda 65
HK - Hong Kong 62
CA - Canada 60
BE - Belgio 57
ES - Italia 48
KR - Corea 48
JP - Giappone 46
AT - Austria 40
CZ - Repubblica Ceca 32
AU - Australia 31
MX - Messico 20
CH - Svizzera 19
CI - Costa d'Avorio 19
IQ - Iraq 18
VN - Vietnam 18
PE - Perù 17
EU - Europa 16
UZ - Uzbekistan 15
ZA - Sudafrica 15
BG - Bulgaria 14
PH - Filippine 14
AR - Argentina 13
EG - Egitto 13
IL - Israele 13
LT - Lituania 13
RO - Romania 13
TW - Taiwan 13
CL - Cile 12
PK - Pakistan 11
PT - Portogallo 10
HU - Ungheria 8
TH - Thailandia 8
TN - Tunisia 8
AL - Albania 7
AZ - Azerbaigian 7
HR - Croazia 7
MA - Marocco 7
NZ - Nuova Zelanda 7
BD - Bangladesh 6
CO - Colombia 6
SI - Slovenia 6
EC - Ecuador 5
EE - Estonia 5
GR - Grecia 5
NO - Norvegia 5
AM - Armenia 4
BY - Bielorussia 4
CY - Cipro 4
KG - Kirghizistan 4
SA - Arabia Saudita 4
SK - Slovacchia (Repubblica Slovacca) 4
DK - Danimarca 3
KH - Cambogia 3
KZ - Kazakistan 3
LA - Repubblica Popolare Democratica del Laos 3
LK - Sri Lanka 3
LV - Lettonia 3
MK - Macedonia 3
NG - Nigeria 3
NP - Nepal 3
BO - Bolivia 2
BZ - Belize 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
JM - Giamaica 2
KW - Kuwait 2
LU - Lussemburgo 2
MD - Moldavia 2
PA - Panama 2
RS - Serbia 2
SY - Repubblica araba siriana 2
SZ - Regno dello Swaziland 2
VE - Venezuela 2
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CM - Camerun 1
CR - Costa Rica 1
GE - Georgia 1
Totale 15.939
Città #
Chandler 1.397
Singapore 714
Ashburn 525
Dublin 340
Jacksonville 239
Rome 236
Warsaw 231
Jakarta 228
San Mateo 202
New York 184
Ann Arbor 170
Beijing 154
Wilmington 154
Milan 153
Nanjing 145
Boston 141
Cattolica 125
Marseille 118
Princeton 115
Los Angeles 107
Fairfield 102
Dearborn 90
Woodbridge 88
Helsinki 86
Moscow 86
Redwood City 85
The Dalles 79
Seattle 77
Houston 76
Nürnberg 71
Frankfurt am Main 70
Izmir 68
Munich 68
North Bergen 66
Boardman 63
Lawrence 62
Bremen 59
Hangzhou 56
Nuremberg 51
London 48
Brussels 47
Nanchang 46
Redmond 42
Shanghai 41
Pune 39
Düsseldorf 37
Hebei 36
Shenyang 36
Augusta 34
São Paulo 34
Chicago 33
Mountain View 33
Hyderabad 32
Lancaster 32
Cambridge 31
Tianjin 31
Hong Kong 30
Kunming 29
Changsha 28
Guangzhou 27
Washington 27
Zhengzhou 27
Detroit 26
Norwalk 26
Seoul 26
Toronto 24
Paris 23
Kish 22
Trieste 22
Vienna 22
Jiaxing 21
Kraków 21
Fremont 20
Tokyo 20
Abidjan 19
Falkenstein 19
Lappeenranta 19
Andover 17
Leawood 17
Portsmouth 17
Naples 16
Tehran 16
Lauterbourg 15
Monza 15
San Diego 14
Zurich 14
Central 13
Ottawa 13
Brno 12
Hefei 12
Newark 12
University Park 12
Busto Arsizio 11
Jinan 11
Madrid 11
Melbourne 11
Baghdad 10
Belo Horizonte 10
Council Bluffs 10
Lanzhou 10
Totale 8.510
Nome #
The interpaly between immune system and microbiota in gynecological diseases : a narrative review. 575
Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility 299
Food Components and Dietary Habits: Keys for a Healthy Gut Microbiota Composition. 218
International consensus conference on stool banking for faecal microbiota transplantation in clinical practice 206
Gut Microbiota Modulation and Mucosal Immunity: Focus on Rifaximin 189
Asthma in patients admitted to emergency department for COVID-19: prevalence and risk of hospitalization 171
The role of diet on gut microbiota composition 165
Propionyl-L-carnitine hydrochloride for treatment of mild to moderate colonic inflammatory bowel diseases 162
Anti-TNF-α-induced psoriasiform lesions in IBD: an abnormal immune activation or a 'patchy cutaneous' immune suppression? 160
Management of acute dyarrhea: current and future trends 150
The gut barrier: new acquisitions and therapeutic approaches 149
Vascular involvement in inflammatory bowel disease: pathogenesis and clinical aspects. 142
Nutrition and IBD: Malnutrition and/or Sarcopenia? A Practical Guide 139
Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises From a First Meta-Analysis 139
Role and mechanisms of action of Escherichia coli nissle 1917 in the maintenance of remission in ulcerative colitis patients: an update 138
Bacterial flora as a cause or treatment of chronic diarrhea 136
Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders? 135
Gelatin tannate ameliorates acute colitis in mice by reinforcing mucus layer and modulating gut microbiota composition: Emerging role for 'gut barrier protectors' in IBD? 132
13C-octanoic acid breath test to study gastric emptying time 131
Assessment of neurological manifestations in hospitalized patients with COVID-19 131
Comparison between clinical and radiological evaluation before and after medical therapy in patients with Crohn's disease: new prospective roles of CT enterography 126
Complex Muco-cutaneous Manifestations of CARMIL2-associated Combined Immunodeficiency: A Novel Presentation of Dysfunctional Epithelial Barriers 126
Intercellular adhesion molecule 1 gene polymorphisms in inflammatory bowel disease 125
Comparison between clinical and radiological evaluation before and after medical therapy in patients with Crohn's disease: new prospective roles of CT enterography 121
Locally injected Infliximab ameliorates murine DSS colitis: differences in serum and intestinal levels of drug between healthy and colitic mice 120
Skeletal muscle-gut axis: Emerging mechanisms of sarcopenia for intestinal and extra intestinal diseases 120
The therapeutic management of gut barrier leaking: the emerging role for mucosal barrier protectors 116
Validation of an LC-MS/MS Method for Urinary Lactulose and Mannitol Quantification: Results in Patients with Irritable Bowel Syndrome 113
The Role of Antibiotics in Gut Microbiota Modulation: The Eubiotic Effects of Rifaximin 111
Dietary magnesium: the magic mineral that protects from colon cancer? 108
Locally injected Infliximab ameliorates murine DSS colitis: differences in serum and intestinal levels of drug between healthy and colitic mice 107
Use and indications of cholestyramine and bile acid sequestrants 104
Mucosal biomarkers in inflammatory bowel disease: key pathogenic players or disease predictors? 103
The gastrointestinal microbiome - functional interference between stomach and intestine 102
Intestinal gas production and gastrointestinal symptoms: from pathogenesis to clinical implication 101
Tumour necrosis factor-related apoptosis-inducing ligand (trail): a possible pathogenic role in chronic plaque psoriasis 101
Acute refractory intestinal pseudo-obstruction in MELAS: efficacy of prucalopride 100
Gut microbial flora, prebiotics and probiotics in IBD: their current usage and utility 99
Rifaximin for the treatment of diarrhoea-predominant irritable bowel syndrome 98
European consensus conference on faecal microbiota transplantation in clinical practice 98
Therapy experiences and preferences among patients with anemia: Results of a cross-sectional survey among Italian patients with inflammatory bowel disease 98
-Extraintestinal manifestations in inflammatory Bowel disease. 97
Differential CD133 expression pattern during mouse colon tumorigenesis 97
Tricks for interpreting and making a good report on hydrogen and 13C breath tests 97
Dysbiosis, gut microbiota modulation and intestinal permeability in recurrent cystitis patients and concomitant gastrointestinal pathologies 97
RECURRENT PREGNANCY LOSS IS ASSSOCIATED TO LEAKY GUT: A NOVEL PATHOGENIC MODEL OF ENDOMETRIUM INFLAMMATION ? 96
Origin of celiac disease: How old are predisposing haplotypes? 94
Commensal Clostridia: leading players in the maintenance of gut homeostasis 93
Use and indications of cholestyramine and bile acid sequestrants 93
Pre- and posttherapy assessment of intestinal soluble mediators in IBD: where we stand and future perspectives 93
Prevention and treatment of venous thromboembolism in patients with IBD: a trail still climbing. 93
Sustainability of Endovenous Iron Deficiency Anaemia Treatment: Hospital-Based Health Technology Assessment in IBD Patients 93
A novel pathogenic role for microvasculature in inflammatory bowel disease. 92
Pre- and posttherapy assessment of intestinal soluble mediators in IBD: where we stand and future perspectives 91
A) Platelets: new players in the mucosal scenario of inflammatory bowel disease. 88
Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility 88
Herbal medicinal products for inflammatory bowel disease: A focus on those assessed in double-blind randomised controlled trials 87
Akkermansia muciniphila: key player in metabolic and gastrointestinal disorders 87
Bacillus clausii and gut homeostasis: state of the art and future perspectives 86
Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in Italy 85
Specific 13C functional pathways as diagnostic targets in gastroenterology breath-tests: tricks for a correct interpretation 84
Clinical, histopathological, and immunological evaluation of a series of patients with erythema nodosum 82
Pancreatic function assessment 79
Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab 79
Anti-TNF-related leukocytoclastic vasculitis in ulcerative colitis: a case report 79
Small bowel bacterial overgrowth and type 1 diabetes 78
Palaeodiet reconstruction in a woman with probable celiac disease: a stable isotope analysis of bone remains from the archaeological site of Cosa (Italy) 78
Prevention and treatment of venous thromboembolism in patients with IBD: a trail still climbing 78
Multiparametric Evaluation Predicts Different Mid-Term Outcomes in Crohn's Disease 78
Haemostatic system in inflammatory bowel diseases: new players in gut inflammation. 77
Gut microbiota and inflammatory bowel disease: an update 77
Characterization of Sarcopenia in an IBD Population Attending an Italian Gastroenterology Tertiary Center 77
Direct effect of infliximab on intestinal mucosa sustains mucosal healing: Exploring new mechanisms of action 77
Signs of dissociation and symptoms of post-traumatic stress disorder in inflammatory bowel disease. A case-control study 77
Tumour necrosis factor-related apoptosis-inducing ligand (trail): a possible pathogenic role in chronic plaque psoriasis 76
Dietary Magnesium Alleviates Experimental Murine Colitis Through Upregulation of the Transient Receptor Potential Melastatin 6 Channel 76
The current practice of lynch syndrome diagnosis and management in Italy: A qualitative assessment 76
Endoscopic ultrasound-guided fine-needle tissue acquisition from a subepithelial lesion in the distal ileum using the forward-viewing echoendoscope 75
Microbes and Alzheimer' disease: Lessons from H. Pylori and GUT microbiota 75
Secretome modulation of Caco-2 cell line induced by a multi-strain probiotic 74
Gut Microbiota: A Key Modulator of Intestinal Healing in Inflammatory Bowel Disease 73
Mesenchymal Stem Cells Reduce Colitis in Mice via Release of TSG6, Independently of Their Localization to the Intestine 72
Can we predict the efficacy of anti-TNF-α agents? 70
Microparticles produced by activated platelets carry a potent and functionally active angiogenic signal in subjects with crohn’s disease 70
Correction to: Recurrent pregnancy loss is associated to leaky gut: a novel pathogenic model of endometrium inflammation? 70
Exploring Bacteroidetes: Metabolic key points and immunological tricks of our gut commensals 70
Cancer and Mediterranean Diet: A Review 70
Tumor necrosis factor-α and solute carrier family 22 member 4 gene polymorphisms as potential determinants of intestinal dysbiosis 70
Drug-Related Pneumonitis in Patients Receiving Vedolizumab Therapy for Inflammatory Bowel Disease 69
Combination therapy in inflammatory bowel disease – from traditional immunosuppressors towards the new paradigm of dual targeted therapy 68
Gemelli decision tree Algorithm to Predict the need for home monitoring or hospitalization of confirmed and unconfirmed COVID-19 patients (GAP-Covid19): preliminary results from a retrospective cohort study 67
Intestinal permeability in physiological and pathological conditions: major determinants and assessment modalities 67
Enterography CT without and with water enema in patients with Crohn's disease: Results from a comparative observational study in comparison with endoscopy 64
Acute refractory intestinal pseudo-obstruction in melas: Efficacy of prucalopride 64
Bacillus clausii for the treatment of acute diarrhea in children: A systematic review and meta-analysis of randomized controlled trials 64
Long-term evaluation of quality of life and gastrointestinal well-being after segmental colo-rectal resection for deep infiltrating endometriosis (ENDO-RESECT QoL) 64
Crohn's disease activity before and after medical therapy evaluated by MaRIA score and others parameters in MR Enterography. 64
Bowel contrast-enhanced ultrasound perfusion imaging in the evaluation of Crohn's disease patients undergoing anti-TNFα therapy 64
Considering gut microbiota disturbance in the management of Helicobacter pylori infection 63
Impact of the Trophic Effects of the Secretome From a Multistrain Probiotic Preparation on the Intestinal Epithelia 63
Totale 10.609
Categoria #
all - tutte 81.791
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.791


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020271 0 0 0 0 0 0 0 0 0 0 173 98
2020/20211.193 58 141 20 116 176 89 133 24 126 75 202 33
2021/20221.744 120 83 37 101 123 57 26 241 86 190 345 335
2022/20233.972 513 511 298 603 239 467 197 345 456 82 163 98
2023/20242.429 106 539 100 155 100 321 189 97 129 139 269 285
2024/20253.273 103 152 432 156 432 201 316 214 642 596 29 0
Totale 16.277